PhaseBio Pharmaceuticals Inc
PHASDelisted Dec 21, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001169245
PhaseBio Pharmaceuticals Inc was delisted on Dec 21, 2022; its insiders filed their last Form 4 on May 19, 2023; 39 institutions reported holding it in 13F filings for Q3 2022, worth $3.90M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding PhaseBio Pharmaceuticals Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 56 | 1 | 62 | +7 |
| Shares | 30.5M | 1.61M | 30.8M | +2.00M (+6.9%) |
| Value | $113.3M | $5.98M | $95.9M | −$11.4M (−10.6%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held PhaseBio Pharmaceuticals Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Johnson & Johnson | 1,607,044 | $5.00M | 0.44% |
| Eversept Partners, LP | 300,000 | $933.0K | 0.07% |
| Caas Capital Management LP | 263,172 | $818.0K | 0.06% |
| Marshall Wace, LLP | 218,877 | $681.0K | 0.00% |
| OrbiMed Advisors LLC | 177,113 | $551.0K | 0.01% |
| Renaissance Technologies LLC | 100,566 | $313.0K | 0.00% |
| Jump Financial, LLC | 43,867 | $136.0K | 0.01% |
| Jacobs Levy Equity Management, Inc | 31,324 | $97.0K | 0.00% |
| HRT Financial LP | 28,286 | $87.0K | 0.00% |
| Pura Vida Investments, LLC | 27,944 | $87.0K | 0.01% |
| Acadian Asset Management LLC | 12,550 | $39.0K | 0.00% |
| XTX Topco Ltd | 11,215 | $35.0K | 0.01% |
| Federated Hermes, Inc. | 316 | $1.00K | 0.00% |
Sold out (6)
Institutions that held PhaseBio Pharmaceuticals Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 186,031 | $692.0K |
| Tibra Equities Europe Ltd | 91,200 | $339.0K |
| Charles Schwab Investment Management Inc | 17,190 | $64.0K |
| Parametric Portfolio Associates LLC | 10,254 | $38.0K |
| Captrust Financial Advisors | 521 | $2.00K |
| New York State Common Retirement Fund | 106 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held PhaseBio Pharmaceuticals Inc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 1,607,044 | $5.98M |